Date | Event | Description |
---|---|---|
9 February 2021 | Review declared as stable | Heparin is currently the standard of care for ACS; thus, it is no longer compared with a placebo (there are no new trials that fit eligibility criteria). |
Date | Event | Description |
---|---|---|
9 February 2021 | Review declared as stable | Heparin is currently the standard of care for ACS; thus, it is no longer compared with a placebo (there are no new trials that fit eligibility criteria). |